Genetic polymorphisms of tumour necrosis factor alpha (TNF-α) promoter gene and response to TNF-α inhibitors in Spanish patients with inflammatory bowel disease

International Journal of Immunogenetics

Volumn 41, Issue 1, 2014, Pages 63-68

  Lopez Hernandez R ^a   Valdes M ^a   Campillo, J A ^a   Martinez Garcia P ^a   Salama, H ^a   Salgado, G ^a   Boix, F ^a   Moya Quiles, M R ^a   Minguela, A ^b   Sanchez Torres A ^a   Miras, M ^a   Garcia, A ^a   Carballo, F ^a   Alvarez Lopez M R ^b   Muro, M ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CERTOLIZUMAB PEGOL; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE PREDISPOSITION; DNA DETERMINATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; TREATMENT RESPONSE; ULCERATIVE COLITIS; YOUNG ADULT;

ADOLESCENT; ADULT; ALLELES; CHILD; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; SPAIN; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84892373860     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/iji.12059     Document Type: Article

References (32)

1. Ahmad, T. & Jewel, D. (2006) Genetics of inflammatory bowel disease: the role of the HLA complex. World Journal of Gastroenterology, 12, 3628.
2. Anderson, C.A., Boucher, G., Lees, C.W., Franke, A., D'Amato, M. Taylor, K.D. et al. (2011) Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nature Genetics, 43, 246.
3. Ben-Horin, S. & Chowers, Y. (2011) Loss of response to anti-TNF treatments in Crohn's disease. Alimentary Pharmacology & Therapeutics, 33, 987.
4. Bradley, J.R. (2008) TNF-mediated inflammatory disease. Journal of Pathology, 214, 149.
5. Cromer, W.E., Mathis, M., Granger, D.N., Chaitanya, G.V. & Alexander, J.S. (2011) Role of the endothelium in inflammatory bowel diseases. World Journal of Gastroenterology, 17, 578.
6. Danese, S. (2011) Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases. World Journal of Gastroenterology, 17, 547.
7. Estrada, C., Gómez, C., Martín, C., Moncada, S. & González, C. (1992) Nitric oxide mediates tumor necrosis factor-alpha cytotoxicity in endothelial cells. Biochemical and Biophysical Research Communications, 186, 475.
8. Ferguson, L.R., Huebner, C., Petermann, I., Gearry, R.B., Barclay, M.L., Demmers, P., McCulloch, A. & Han, D.Y. (2008) Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases risk. World Journal of Gastroenterology, 14, 4652.
9. Fowler, E.V., Eri, R., Hume, G., Johnstone, S., Pandeya, N., Lincoln, D., Templeton, D. & Radford-Smith, G.L. (2005) TNFa and IL10 SNPs act together to predict disease behaviour in Crohn's disease. Journal of Medical Genetics, 42, 523.
10. a promoter polymorphism is associated with enhanced TNF-α production and inflammatory activity in Crohn's patients with fistulizing disease. American Journal of Gastroenterology, 98, 1101.
11. López-Alvarez, M.R., Moya-Quiles, M.R., Minguela, A., Gil, J., Miras, M., Campillo, J.A. et al. (2009) HLA-C matching and liver transplants. Donor-recipient genotypes influence early outcome and CD8 + KIR2D+ T cells recuperation. Transplantation, 88, S54.
12. López-Hernández, R., Valdés, M., Lucas, D., Campillo, J.A., Martínez-Garcia, P., Salama, H. et al. (2010) Association analysis of the MICA gene polymorphism and MICA-129 dimorphism and inflammatory bowel disease susceptibility in a Spanish population. Human Immunology, 71, 512.
13. Louis, E., Vermeire, S., Rutgeerts, P., De Vos, M., VanGossum, A., Pescatore, P. et al. (2003) A positive response to infliximab in Crohn disease: association with a higher systemic inflammation before treatment but not with -308 TNF gene polymorphism. Scandinavian Journal of Gastroenterology, 37, 818.
14. Lucas, D., Campillo, J.A., López-Hernández, R., Martínez-García, P., López-Sánchez, M., Botella, C., Salgado, G., Minguela, A., Alvarez-López, M.R. & Muro, M. (2008) Allelic diversity of MICA gene and MICA/HLA-B haplotypic variation in a population of the Murcia region in southeastern Spain. Human Immunology, 69, 655.
15. Mascheretti, S., Hampe, J., Kühbacher, T., Herfarth, H., Krawczak, M., Fölsch, U.R. & Schreiber, S. (2002) Pharmacogenetic investigation of the TNF/TNF-receptor system in patients with chronic active Crohn's disease treated with infliximab. The Pharmacogenomics Journal, 2, 127.
16. Matsukura, H., Ikeda, S., Yoshimura, N., Takazoe, M. & Muramatsu, M. (2008) Genetic polymorphisms of tumour necrosis factor superfamily 1A and 1B affect responses to infliximab in Japanese patients with Crohn′s disease. Alimentary Pharmacology & Therapeutics, 27, 765.
17. Muro, M., Marín, L., Torío, A., Moya-Quiles, M.R., Minguela, A., Rosique-Roman, J., Sanchis, M.J., Garcia-Calatayud, M.C., García-Alonso, A.M. & Alvarez-López, M.R. (2001) HLA polymorphism in the Murcia Population (Spain) in the Cradle of the Archaeologic Iberians. Human Immunology, 62, 910.
18. Muro, M., Lopez, R., Campillo, J.A., Salama, H., Martinez, P., Lucas, D. et al. (2009) The Role of Human Leukocyte Antigen (HLA) complex in IBD: Crohn′s disease and ulcerative colitis. Advanced Studies in Biology, 1, 37.
19. Muro, M., González-Soriano, M.J., Salgado, G., López, R., Boix, F., López, M. et al. (2010a) Specific "intra-allele" (IA) and "intra-broad antigen" (IBA) HLA alloantibodies in kidney graft transplantation. Human Immunology, 71, 857.
20. Muro, M., Lopez, R., Campillo, J.A., Martinez, P., Lucas, D., Botella, C., Minguela, A. & Alvarez, R. (2010b) Recent advances in basic and clinical aspects in inflammatory bowel diseases, as Crohn′s disease and ulcerative colitis: role of gastrointestinal granulocytes. In: Advances in Medicine and Biology, Vol 2. (ed. L. Berhardt), pp. 37-53. Nova Science Publishers, Inc., New York, USA.
21. Paul, A.T., Gohil, V.M. & Bhutani, K.K. (2006) Modulating TNF-alpha signalling with natural products. Drug Discovery Today, 11, 725.
22. Pierik, M., Yang, H., Barmada, M.M., Cavanaugh, J.A., Annese, V., Brant, S.R. et al. (2005) The IBD international genetics consortium provides further evidence for linkage to IBD4 and shows gene-environment interaction. Inflammatory Bowel Diseases, 11, 1.
23. Pober, J.S., Lapierre, L.A., Stolpen, A.H., Brock, T.A., Springer, T.A., Fiers, W., Bevilacqua, M.P., Mendrick, D.L. & Gimbrone, M.A. Jr. (1987) Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species. Journal of Immunology, 138, 3319.
24. Podolsky, D.K. (2002) Inflammatory bowel disease. New England Journal of Medicine, 347, 417.
25. Slowik, M.R., De Luca, L.G., Fiers, W. & Pober, J.S. (1993) Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration. American Journal of Pathology, 143, 1724.
26. Steenholdt, C., Svenson, M., Bendtzen, K., Thomsen, O., Brynskov, J. & Ainsworth, M.A. (2011) Severe infusion reactions to infliximab: aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 34, 51.
27. Stokkers, P.C. & Hommes, D.W. (2004) New cytokine therapeutics for inflammatory bowel disease. Cytokine, 28, 167.
28. Suárez-Alvarez, B., López-Vázquez, A., Gonzalez, M.Z., Fdez-Morera, J.L., Díaz-Molina, B., Blanco-Gelaz, M.A. et al. (2007) The relationship of Anti-MICA antibodies and MICA expression with heart allograft rejection. American Journal of Transplantation, 7, 1842.
29. van Heel, D.A., Udalova, I.A., De Silva, A.P., McGovern, D.P., Kinouchi, Y., Hull, J. et al. (2002) Inflammatory bowel disease is associated with a TNF polymorphism that effects an interaction between the OCT1 and NF-kB transcription factors. Human Molecular Genetics, 11, 1281.
30. van Heel, D., Fisher, S.A., Kirby, A., Daly, M.J., Rioux, J.D. & Lewis, C.M. (2004) Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Human Molecular Genetics, 13, 763.
31. Wilson, A.G., Symons, J.A., McDowell, T.L., McDevitt, H.O. & Duff, G.W. (1997) Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation. Proceedings of the National Academy of Sciences of the United States of America, 94, 3195.
32. Yoshizumi, M., Perrella, M.A., Burnett, J.C. Jr & Lee, M.E. (1993) Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circulation Research, 73, 205.